RESUMO
Objective: To assess the impact of proton pump inhibitors (PPIs) on cardiovascular health and performance in elite athletes. This study aims to understand the utilization patterns, potential cardiovascular implications, and performance outcomes associated with PPI use in this specific population. Methods: A comprehensive review of PPI use among elite athletes was conducted, including a detailed analysis of medication type, dosage, frequency, and duration. The study involved a retrospective examination of medical and training records of athletes whoused PPIs in 2021. The analysis focused on evaluating the correlation between PPI use and cardiovascular health markers, as well as performance metrics in these athletes. Results: The study found a significant prevalence of PPI use among elite athletes, primarily for managing exercise-induced gastrointestinal symptoms. Key findings include: (1) a notable variation in the type and dosage of PPIs used; (2) a correlation between long-term PPI use and certain cardiovascular health markers; (3) athletes on PPIshad varied performance outcomes, with some showing decreased endurance. Conclusion: The study highlights the need for a more nuanced understanding of PPI use in elite athletes, emphasizing the importance of personalized medical guidance. While PPIs can bebeneficial for managing specific gastrointestinal issues in athletes, their impact on cardiovascular health and athletic s requires careful consideration and monitoring. This research underscores the necessity for developing tailored medication strategiesfor elite athletes to optimize health and performance outcomes (AU)
